Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
-NHF and Community News
 Industry News
 Travel Advisory

 

 

 
Research is Our Future Nears Campaign Goal
 

NHF is thrilled to announce that an additional $200,000 has been raised from individuals and families affected by bleeding disorders, as well as NHF chapters, toward Research is Our Future, NHF’s national campaign advancing our research program.  Combined with Novo Nordisk’s previously announced additional gift of $600,000, NHF is within $400,000 of achieving our $1.2 million goal for research support and our ultimate campaign goal of $8.5 million.

 

Research is our Future Phase II of NHF’s Campaign for Our Future was launched in November 2008.  It provides an opportunity for all members of the community to get involved and truly become part of our future by providing the resources needed to improve treatments and accelerate a cure for bleeding disorders.

 

For more information about the campaign, please contact Mary Ann Ludwig, NHF’s Vice President for Development: 212.328.3741. To learn more about Research is Our Future, or to make a contribution, please visit www.hemophilia.org/campaignforourfuture.

 

NHF acknowledges all of our 2010 Corporate Partners of the Campaign for our Future: Visionary Corporate Partner and Lead Benefactor Novo Nordisk; Principal Corporate Partner Baxter; Major Corporate Partners Bayer HealthCare, CSL Behring and Pfizer; and Corporate Partner Grifols.

 

This section of our Web site is sponsored by: